| Literature DB >> 32615956 |
Long Chen1, Zeyu Sun1, Jingming He1, Yunwen Xu2, Zhuhai Li3, Qian Zou1, Bo Li4.
Abstract
BACKGROUND: Adolescent idiopathic scoliosis (AIS) is the most common form of spinal deformity in children and adolescents which presents as complex three-dimensional (3D) deformity of the spine and rib cage. This study aimed to estimate the effectiveness and safety of surgical interventions for AIS using Bayesian meta-analysis.Entities:
Keywords: Adolescent idiopathic scoliosis; Bayesian meta-analysis; Cobb angle; Complications; Pulmonary function; Surgical interventions
Mesh:
Year: 2020 PMID: 32615956 PMCID: PMC7333422 DOI: 10.1186/s12891-020-03233-1
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Flow chart Showing Selection of Studies
Characteristics of the 28 included studies
| Source | Study design | Country | Interventions | Sample size | Follow-up (year) | Outcomes for analysis |
|---|---|---|---|---|---|---|
| Dobbs 2006 [ | Retrospective nonrandomized controlled trial | USA | ASR + PSF vs PSF | 20/34 | 2.4 | ① |
| Zhang 2012 [ | Prospective nonrandomized controlled trial | China | ASR + PSF vs PSF | 31/33 | 2 | ①, ④ |
| Zhang 2009 [ | Retrospective nonrandomized controlled trial | China | ASR + PSF vs PSF | 32/94 | 3.4 | ① |
| Qiu 2011 [ | Retrospective nonrandomized controlled trial | China | VAT+PSF vs PSF | 18/27 | 3.65 | ①, ④ |
| Zhang 2011 [ | Retrospective nonrandomized controlled trial | China | ASR + PSF vs PSF | 12/17 | 3 | ① |
| Kim 2005 [ | Prospective nonrandomized controlled trial | USA | PSF vs WT vs ASF vs ASR + PSF | 49/41/16/12 | 5 | ① |
| Bullmann 2013 [ | Prospective nonrandomized controlled trial | Germany | ASF vs WT | 40/29 | 2 | ①, ③, ④ |
| Vedantam 2000 [ | Prospective nonrandomized controlled trial | USA | PSF vs WT vs ASF vs ASR + PSF | 47/33/7/11 | 2 | ①, ②, ③ |
| Kim 2008 [ | Retrospective nonrandomized controlled trial | USA | WT vs ASF | 35/29 | 2 | ②, ③ |
| Faro 2005 [ | Prospective nonrandomized controlled trial | USA | VAT vs ASF | 31/23 | 1 | ①, ②, ③ |
| Kishan 2007 [ | Prospective nonrandomized controlled trial | USA | VAT vs WT | 36/43 | 2 | ②, ③ |
| Lenke 2004 [ | Prospective nonrandomized controlled trial | USA | VAT+PSF vs ASR + PSF | 21/16 | 2 | ①, ②, ③ |
| Verma 2011 [ | Retrospective nonrandomized controlled trial | USA | PSF vs ASF vs VAT vs VAT+PSF | 70/35/32/22 | 2 | ②, ③, ④ |
| Zhou 2011 [ | Retrospective nonrandomized controlled trial | China | PSF vs WT | 24/20 | 2 | ①, ②, ③, ④ |
| Greggi 2010 [ | Retrospective nonrandomized controlled trial | Italy | WT vs PSF | 40/40 | 5 | ①, ②, ③, ④ |
| Lonner 2009 [ | Retrospective nonrandomized controlled trial | USA | VAT vs PSF | 17/17 | 2 | ④ |
| Newton 2013 [ | Prospective nonrandomized controlled trial | USA | VAT vs ASF vs PSF | 55/17/77 | 2 | ②, ③, ④ |
| Suk 2008 [ | Retrospective nonrandomized controlled trial | Korea | PSF vs WT | 37/20 | 2 | ①, ②, ③, ④ |
| Graham 2000 [ | Prospective nonrandomized controlled trial | USA | WT vs ASF | 31/20 | 2 | ②, ③ |
| Miljenko 2006 [ | Prospective nonrandomized controlled trial | Croatia | ASF vs PSF | 25/25 | 2 | ① |
| Lenke 1999 [ | Prospective nonrandomized controlled trial | USA | ASF vs PSF | 70/53 | 2 | ① |
| Wong 2004 [ | Retrospective nonrandomized controlled trial | Singapore | PSF vs VAT | 19/12 | 2 | ④ |
| Muschik 2006 [ | Retrospective nonrandomized controlled trial | Germany | ASF vs PSF | 37/104 | 2 | ①, ④ |
| Lonner 2006 [ | Retrospective nonrandomized controlled trial | USA | VAT vs PSF | 28/23 | 2 | ④ |
| Hee 2007 [ | Retrospective nonrandomized controlled trial | Singapore | ASF vs PSF | 25/11 | 3.7 | ① |
| Wang 2008 [ | Prospective nonrandomized controlled trial | China | ASF vs PSF | 16/16 | 2 | ① |
| Dong 2015 [ | Retrospective nonrandomized controlled trial | China | ASF vs PSF | 17/36 | 2 | ①, ④ |
| Zhan 2010 [ | Retrospective nonrandomized controlled trial | China | ASF vs PSF | 22/20 | 2 | ①, ④ |
AIS adolescent idiopathic scoliosis; ①: change of Cobb angle; ②: change of absolute forced vital capacity (FVC); ③: change of absolute forced expiratory volume in 1 s (FEV1); ④: incidence of complications; ASR + PSF combined anterior release and posterior fusion with instrumentation, VAT+PSF combined video assisted anterior release and posterior fusion with instrumentation without thoracoplasty, PSF posterior fusion with instrumentation without thoracoplasty, ASF anterior fusion with instrumentation and thoracotomy without thoracoplasty, VAT video assisted anterior fusion with instrumentation without thoracoplasty, WT any scoliosis surgery with additional thoracoplasty or multiple convex rib resections
Quality assessment of case-controlled studies comparing surgical interventions for treating AIS using Newcastle-Ottawa Scale
| Author group | Selection | Comparability | Exposure | |||||
|---|---|---|---|---|---|---|---|---|
| Adequat-e case definitio-n | Representativeness of the cases | Selectio-n of Control-s | Definitio-n of Controls | Comparability of cases and controls | Ascertainm-ent of exposure | Same method of ascertainmen-t | Non Response rate | |
| Dobbs 2006 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Zhang 2012 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Zhang 2009 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Qiu 2011 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Zhang 2011 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Kim 2005 [ | 1 | 1 | – | 1 | 1 | 1 | 1 | – |
| Bullmann 2013 [ | 1 | 1 | – | 1 | 1 | 1 | 1 | – |
| Vedantam 2000 [ | 1 | 1 | – | 1 | 1 | 1 | 1 | – |
| Kim 2008 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Faro 2005 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Kishan 2007 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Lenke 2004 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Verma 2011 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Zhou 2011 [ | 1 | 1 | – | 1 | 1 | 1 | 1 | – |
| Greggi 2010 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Lonner 2009 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Newton 2013 [ | 1 | 1 | – | 1 | 1 | 1 | 1 | – |
| Suk 2008 [ | 1 | 1 | – | 1 | 1 | 1 | 1 | – |
| Graham 2000 [ | 1 | 1 | – | 1 | 1 | 1 | 1 | – |
| Miljenko 2006 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Lenke 1999 [ | 1 | 1 | – | 1 | 1 | 1 | 1 | – |
| Wong 2004 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | 1 |
| Muschik 2006 [ | 1 | 1 | – | 1 | 1 | 1 | 1 | – |
| Lonner 2006 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Hee 2007 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Wang 2008 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Dong 2015 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
| Zhan 2010 [ | 1 | 1 | – | 1 | 2 | 1 | 1 | – |
AIS adolescent idiopathic scoliosis
Fig. 2Network and rank probability plots for change of absolute FVC and FEV1. For the network plots: the size of the node corresponds to the total sample size of treatments, directly comparable treatments are linked with a line, and the thickness of which represents the number of trials that were compared. FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; ASR + PSF: combined anterior release and posterior fusion with instrumentation; VAT+PSF: combined video assisted anterior release and posterior fusion with instrumentation without thoracoplasty; PSF: posterior fusion with instrumentation without thoracoplasty; ASF: anterior fusion with instrumentation and thoracotomy without thoracoplasty; VAT: video assisted anterior fusion with instrumentation without thoracoplasty; WT: any scoliosis surgery with additional thoracoplasty or multiple convex rib resections
Statistical analysis results from Bayesian meta-analysis (gray background) and pairwise meta-analysis (white background)
AIS adolescent idiopathic scoliosis, FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, ASR + PSF combined anterior release and posterior fusion with instrumentation, VAT+PSF combined video assisted anterior release and posterior fusion with instrumentation without thoracoplasty, PSF posterior fusion with instrumentation without thoracoplasty, ASF anterior fusion with instrumentation and thoracotomy without thoracoplasty, VAT video assisted anterior fusion with instrumentation without thoracoplasty, WT any scoliosis surgery with additional thoracoplasty or multiple convex rib resections, NA not applicable
Fig. 3Network and rank probability plots for change of Cobb angle and incidence of complications. For the network plots: the size of the node corresponds to the total sample size of treatments, directly comparable treatments are linked with a line, and the thickness of which represents the number of trials that were compared. ASR + PSF: combined anterior release and posterior fusion with instrumentation; VAT+PSF: combined video assisted anterior release and posterior fusion with instrumentation without thoracoplasty; PSF: posterior fusion with instrumentation without thoracoplasty; ASF: anterior fusion with instrumentation and thoracotomy without thoracoplasty; VAT: video assisted anterior fusion with instrumentation without thoracoplasty; WT: any scoliosis surgery with additional thoracoplasty or multiple convex rib resections
Inconsistency Factors for each outcome
| Outcome | Cycle | Median (95% CrI) |
|---|---|---|
| ASR + PSF; PSF; ASF | −0.44 (− 9.14, 5.87) | |
| ASR + PSF; PSF; ASF; WT | 0.73 (−6.35, 11.07) | |
| ASR + PSF; PSF; VAT+PSF | −0.02 (−9.81, 10.07) | |
| PSF; ASF; WT | −0.45 (− 10.09, 6.72) | |
| PSF; ASF; VAT | 0.07 (−1.54, 1.92) | |
| PSF; ASF; VAT; VAT+PSF | −0.06 (− 2.08, 1.63) | |
| PSF; ASF; WT | −0.04 (− 2.18, 1.66) | |
| PSF; ASF; VAT+PSF | 0.17 (−1.17, 2.62) | |
| ASR + PSF; PSF; ASF; VAT; VAT+PSF | −0.01 (− 0.45, 0.51) | |
| ASR + PSF; PSF; VAT; VAT+PSF | 0.15 (−0.13, 0.86) | |
| ASR + PSF; PSF; VAT+PSF | −0.01 (− 0.44, 0.43) | |
| PSF; ASF; VAT | −0.00 (− 0.53, 0.47) | |
| PSF; ASF; VAT | −0.00 (− 0.53, 0.47) | |
| PSF; ASF; VAT; WT | 0.01 (− 0.42, 0.55) | |
| PSF; ASF; VAT; WT | 0.01 (−0.42, 0.55) | |
| ASF; VAT; WT | −0.09 (− 0.68, 0.20) | |
| ASR + PSF; PSF; VAT+PSF | 0.05 (− 0.36, 0.77) | |
| PSF; ASF; VAT; WT | −0.00 (− 0.52, 0.71) | |
| PSF; ASF; VAT; WT | −0.00 (− 0.52, 0.71) | |
| PSF; VAT; WT | −0.06 (− 0.76, 0.41) | |
| PSF; VAT; WT | −0.06 (− 0.76, 0.41) | |
| ASF; VAT; WT | −0.04 (− 0.76, 0.42) | |
| ASF; VAT; WT | −0.04 (− 0.76, 0.42) |
ASR + PSF combined anterior release and posterior fusion with instrumentation, VAT+PSF combined video assisted anterior release and posterior fusion with instrumentation without thoracoplasty, PSF posterior fusion with instrumentation without thoracoplasty, ASF anterior fusion with instrumentation and thoracotomy without thoracoplasty, VAT video assisted anterior fusion with instrumentation without thoracoplasty, W-T any scoliosis surgery with additional thoracoplasty or multiple convex rib resections, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity
Node-splitting analysis for inconsistency of Bayesian meta-analysis
| Outcome | Comparison | Direct Effect | Indirect Effect | Bayesian Effect | |
|---|---|---|---|---|---|
| ASR + PSF vs PSF | 2.51 (−3.61, 8.50) | − 0.72 (− 11.35, 9.36) | 2.32 (− 3.33, 7.86) | 0.54 | |
| ASR + PSF vs ASF | 5.00 (− 8.04, 16.68) | 3.99 (− 3.65, 11.34) | 4.87 (−2.00, 11.58) | 0.87 | |
| ASR + PSF vs WT | −1.35 (− 12.88, 9.45) | 5.95 (−3.23, 14.94) | 3.58 (−4.03, 10.99) | 0.27 | |
| ASR + PSF vs VAT+PSF | 4.19 (−13.65, 22.04) | 4.34 (− 11.59, 19.54) | 4.06 (−7.20, 15.44) | 1 | |
| PSF vs ASF | 2.79 (−1.98, 7.84) | 0.68 (−15.13, 16.43) | 2.54 (− 1.99, 7.09) | 0.79 | |
| PSF vs WT | 2.36 (−3.81, 8.75) | 2.88 (− 12.15, 17.75) | 1.30 (−4.47, 6.90) | 0.94 | |
| PSF vs VAT+PSF | 2.02 (−11.94, 16.18) | 1.52 (−16.87, 20.19) | 1.74 (−9.06, 12.91) | 0.96 | |
| ASF vs WT | −2.88 (−11.90, 5.60) | 1.27 (−8.31, 10.93) | −1.24 (−7.74, 5.12) | 0.49 | |
| PSF vs ASF | 0.57 (−1.03, 2.07) | 1.14 (−2.80, 5.17) | 0.53 (−0.78, 1.76) | 0.77 | |
| PSF vs WT | 0.26 (−1.73, 2.48) | − 0.38 (−3.99, 3.08) | 0.05 (− 1.57, 1.84) | 0.72 | |
| ASF vs VAT | 0.32 (−2.02, 2.69) | −0.17 (− 2.58, 2.62) | 0.26 (− 1.32, 1.96) | 0.75 | |
| ASF vs WT | −0.85 (−4.21, 2.55) | − 0.19 (− 2.63, 2.59) | −0.48 (− 2.26, 1.54) | 0.73 | |
| ASF vs VAT+PSF | 2.17 (−0.74, 5.60) | −1.16 (−5.64, 2.77) | 1.08 (− 1.28, 3.41) | 0.15 | |
| VAT vs VAT+PSF | 1.30 (−1.85, 4.17) | −1.39 (− 5.94, 2.57) | 0.84 (− 1.59, 3.08) | 0.26 | |
| ASR + PSF vs PSF | 0.49 (−0.23, 1.25) | 0.14 (−0.48, 0.75) | 0.25 (− 0.29, 0.81) | 0.4 | |
| ASR + PSF vs ASF | −0.04 (− 0.83, 0.82) | −0.14 (− 0.75, 0.50) | −0.12 (− 0.69, 0.45) | 0.84 | |
| ASR + PSF vs WT | 0.01 (−0.75, 0.76) | 0.02 (−0.60, 0.62) | − 0.02 (− 0.58, 0.55) | 0.98 | |
| ASR + PSF vs VAT+PSF | −0.13 (− 0.91, 0.66) | 0.56 (− 0.28, 1.40) | 0.21 (− 0.39, 0.79) | 0.23 | |
| PSF vs ASF | − 0.32 (− 0.72, 0.07) | −0.48 (− 0.91, − 0.03) | −0.37 (− 0.69, − 0.06) | 0.56 | |
| PSF vs VAT | − 0.35 (− 0.79, 0.09) | −0.14 (− 0.67, 0.38) | −0.32 (− 0.68, 0.04) | 0.51 | |
| PSF vs WT | −0.28 (− 0.64, 0.07) | −0.28 (− 0.79, 0.23) | −0.27 (− 0.55, 0.02) | 0.97 | |
| PSF vs VAT+PSF | 0.01 (−0.68, 0.70) | −0.56 (− 1.56, 0.47) | −0.04 (− 0.57, 0.48) | 0.34 | |
| ASF vs VAT | −0.07 (− 0.41, 0.27) | 0.46 (− 0.15, 1.08) | 0.05 (− 0.28, 0.39) | 0.11 | |
| ASF vs WT | 0.18 (−0.16, 0.53) | − 0.04 (− 0.53, 0.44) | 0.10 (− 0.18, 0.39) | 0.4 | |
| ASF vs VAT+PSF | 0.34 (− 0.35, 1.01) | −0.20 (− 1.21, 0.81) | 0.33 (− 0.20, 0.86) | 0.35 | |
| VAT vs WT | −0.30 (− 0.89, 0.31) | 0.20 (− 0.20, 0.61) | 0.05 (− 0.32, 0.41) | 0.16 | |
| VAT vs VAT+PSF | 0.65 (0.00, 1.33) | −0.25 (− 1.28, 0.80) | 0.28 (− 0.27, 0.82) | 0.15 | |
| ASR + PSF vs PSF | 0.75 (0.00, 1.50) | 0.35 (−0.26, 0.98) | 0.49 (−0.07, 1.06) | 0.31 | |
| ASR + PSF vs ASF | −0.25 (− 1.03, 0.57) | 0.07 (− 0.55, 0.68) | −0.04 (− 0.62, 0.54) | 0.44 | |
| ASR + PSF vs WT | 0.05 (−0.72, 0.91) | −0.09 (− 0.78, 0.60) | −0.06 (− 0.64, 0.52) | 0.72 | |
| ASR + PSF vs VAT+PSF | −0.00 (− 0.77, 0.75) | 0.53 (− 0.43, 1.44) | 0.19 (− 0.37, 0.77) | 0.36 | |
| PSF vs ASF | −0.54 (− 0.98, − 0.14) | −0.58 (− 1.10, − 0.06) | −0.53 (− 0.87, − 0.21) | 0.91 | |
| PSF vs VAT | − 0.90 (− 1.26, − 0.48) | −0.17 (− 0.50, 0.16) | −0.53 (− 0.95, − 0.10) | 0.02 | |
| PSF vs WT | − 0.47 (− 0.79, − 0.15) | −0.86 (− 1.36, − 0.34) | −0.55 (− 0.85, − 0.25) | 0.17 | |
| PSF vs VAT+PSF | − 0.18 (− 0.90, 0.56) | −0.68 (− 1.68, 0.36) | −0.29 (− 0.85, 0.26) | 0.4 | |
| ASF vs VAT | −0.15 (− 0.56, 0.26) | 0.43 (− 0.19, 1.08) | 0.00 (− 0.38, 0.40) | 0.1 | |
| ASF vs WT | 0.01 (−0.41, 0.46) | − 0.03 (− 0.53, 0.49) | −0.02 (− 0.33, 0.31) | 0.9 | |
| ASF vs VAT+PSF | 0.22 (−0.56, 0.95) | −0.15 (− 1.18, 0.92) | 0.24 (− 0.31, 0.79) | 0.54 | |
| VAT vs WT | −0.40 (− 0.96, 0.14) | 0.22 (− 0.21, 0.69) | −0.03 (− 0.42, 0.40) | 0.07 | |
| VAT vs VAT+PSF | 0.57 (−0.15, 1.34) | −0.16 (− 1.25, 0.92) | 0.23 (− 0.36, 0.83) | 0.23 |
ASR + PSF combined anterior release and posterior fusion with instrumentation, VAT+PSF combined video assisted anterior release and posterior fusion with instrumentation without thoracoplasty, PSF posterior fusion with instrumentation without thoracoplasty, ASF anterior fusion with instrumentation and thoracotomy without thoracoplasty, VAT video assisted anterior fusion with instrumentation without thoracoplasty, W-T any scoliosis surgery with additional thoracoplasty or multiple convex rib resections, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity
Random Effects Standard Deviation of Different Models for Sensitivity Analysis
| Outcome | Model for Random Effects Standard Deviation | Median (95% CI) |
|---|---|---|
| Consistency model | 6.28 (4.20, 9.67) | |
| Inconsistency model | 6.40 (4.31, 9.95) | |
| Consistency model | 1.14 (0.02, 2.31) | |
| Inconsistency model | 1.26 (0.38, 2.39) | |
| Consistency model | 0.29 (0.18, 0.50) | |
| inconsistency model | 0.26 (0.11, 0.49) | |
| Consistency model | 0.27 (0.13, 0.53) | |
| Inconsistency model | 0.24 (0.07, 0.52) |
FEV1 forced expiratory volume in 1 s, FVC forced vital capacity